Previous Article | Next Article 
Infection and Immunity, May 2001, p. 2988-2995, Vol. 69, No. 5
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.5.2988-2995.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Exacerbation of Acanthamoeba Keratitis
in Animals Treated with Anti-Macrophage Inflammatory Protein 2 or
Antineutrophil Antibodies
Michael
Hurt,
Sherine
Apte,
Henry
Leher,
Kevin
Howard,
Jerry
Niederkorn, and
Hassan
Alizadeh*
Department of Ophthalmology, University of
Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390
Received 10 October 2000/Returned for modification 25 November
2000/Accepted 8 February 2001
 |
ABSTRACT |
Neutrophils are thought to be involved in many infectious diseases
and have been found in high numbers in the corneas of patients with
Acanthamoeba keratitis. Using a Chinese hamster model of keratitis, conjunctival neutrophil migration was manipulated to determine the importance of neutrophils in this disease. Inhibition of
neutrophil recruitment was achieved by subconjunctival injection with
an antibody against macrophage inflammatory protein 2 (MIP-2), a
powerful chemotactic factor for neutrophils which is secreted by the
cornea. In other experiments, neutrophils were depleted by
intraperitoneal injection of anti-Chinese hamster neutrophil antibody.
The inhibition of neutrophils to the cornea resulted in an earlier
onset and more severe infection compared to controls. Anti-MIP-2
antibody treatment produced an almost 35% reduction of myeloperoxidase
activity in the cornea 6 days postinfection, while levels of endogenous
MIP-2 secretion increased significantly. Recruitment of neutrophils
into the cornea via intrastromal injections of recombinant MIP-2
generated an initially intense inflammation that resulted in the rapid
resolution of the corneal infection. The profound exacerbation of
Acanthamoeba keratitis seen when neutrophil migration was
inhibited, combined with the rapid clearing of the disease in the
presence of increased neutrophils, strongly suggests that neutrophils
play an important role in combating Acanthamoeba infections
in the cornea.
 |
INTRODUCTION |
The two major infectious diseases of
the cornea that lead to blindness in North America, herpes simplex
virus keratitis (HSVK) and Pseudomonas keratitis, are immune
mediated (26, 30, 38). In both HSVK and
Pseudomonas keratitis, the pathogenesis is dependent on
CD4+ T cells, yet corneal lesions are heavily infiltrated
with neutrophils (13, 15). These neutrophils are recruited
to the cornea in response to the chemokine macrophage inflammatory
protein 2 (MIP-2), which is secreted by corneal cells (12,
50). MIP-2 seems to play a dominant role in neutrophil
recruitment, as neutralizing antibodies produce a sharp decrease in
neutrophil infiltration and significantly reduce the corneal opacity in
HSVK in BALB/c mice (23, 34, 39, 48-50).
Acanthamoeba keratitis is a vision-threatening corneal
infection caused by a free-living, pathogenic amoeba (22,
45). Characteristic disease symptoms include a ring-like opaque
infiltrate underlying an epithelial ulcer along with a
disproportionately higher degree of pain than with other forms of
keratitis (1, 21, 31). Treatment of this disease is very
demanding, consisting of hourly topical applications of brolene,
polyhexamethylene biguanide, or chlorhexidine for several weeks. Even
with such regimented therapies, patients often require corneal
transplants, which can in turn become reinfected by dormant amoebae
(1).
Many Acanthamoeba species are ubiquitous in nature and can
be readily isolated from swimming pools, hot tubs, freshwater, soil,
dust, drinking fountains, eyewash stations, air, and the nasopharyngeal
mucosa of healthy persons (2, 5, 6, 14, 19, 29, 32, 44,
46). Despite the wide distribution of the amoebae, this disease
is largely restricted to the wearers of contact lenses who have
experienced some sort of trauma to the corneal epithelium (2, 7,
36, 41, 45).
Although the precise mechanism by which Acanthamoeba infects
the cornea is unknown, it is believed that corneal trauma is a
prerequisite (27, 41). Upon abrasion, the corneal
epithelium expresses elevated concentrations of mannose-glycoprotein,
to which the amoebae can adhere with high affinity (25,
51). Subsequently, the amoebae penetrate and destroy the corneal
epithelium and gain entry into the underlying stroma, which is
primarily a collagenous matrix (11, 18, 28, 51). Once in
the stroma, the amoebae secrete a collagenase that dissolves the
collagenous matrix (11, 24).
Histological evaluation of Acanthamoeba keratitis lesions in
both human and experimental animals revealed large numbers of neutrophils in the cornea (8, 9, 16, 20). Moreover, it has
been reported that the most severe stromal necrosis in Acanthamoeba lesions is mediated by proteases released by
neutrophils rather than the effects of the amoebae (1,
22). In vitro studies show that neutrophils do not exert
significant activity against Acanthamoeba trophozoites
unless they are activated by T-cell cytokines (37). In
fact, it is possible that infiltrating neutrophils exacerbate the
pathogenesis of corneal disease in a manner similar to that described
for HSVK (50). MIP-2 has been shown to be the primary
chemotactic factor for neutrophil infiltration in rat
lipopolysaccharide-induced inflammation models as well playing a role
in many aspects of wound healing in mice (40, 47).
In this study, therefore, we tested the hypothesis that corneal
infections with Acanthamoeba trophozoites would induce the production of MIP-2, which would in turn promote the recruitment of
neutrophils to the infected cornea. We further predicted that inhibiting neutrophil recruitment would mitigate the clinical features
of Acanthamoeba keratitis in a manner similar to the aforementioned findings with HSVK and Pseudomonas keratitis.
 |
MATERIALS AND METHODS |
Animals.
Chinese hamsters were purchased from Cytogen
Research and Development. All animals used were from 4 to 6 weeks of
age, and all corneas were examined before experimentation to exclude
animals with preexisting corneal defects. Animals were handled in
accordance with the Association of Research in Vision and Ophthalmology
"Statement on the Use of Animals in Ophthalmic and Vision Research"
(http://www.arvo.org/animalst.htm).
Amoebae.
Acanthamoeba castellanii ATCC 30868, originally isolated from a human cornea, was obtained from the American
Type Culture Collection, Manassas, Va. Amoebae were grown as axenic
cultures in peptone-yeast extract-glucose at 35°C with constant
agitation (44).
Contact lens preparation.
Contact lenses were prepared from
Spectra/Por dialysis membrane tubing (Spectrum Medical Industries, Los
Angeles, Calif.) using a 3-mm trephine and heat sterilized. Lenses were
placed in sterile 96-well microtiter plates (Costar, Cambridge, Mass.) and incubated with 3 × 106 A. castellanii
trophozoites at 35°C for 24 h. Attachment of amoebae to the
lenses was verified microscopically before infection (28).
In vivo corneal infections.
Acanthamoeba
keratitis was induced as described previously (17, 42).
Briefly, the Chinese hamsters were anesthetized with ketamine (100 mg/kg; Fort Dodge Laboratories, Fort Dodge, Iowa) injected
peritoneally. Prior to manipulation, the corneas were anesthetized with
Alcain (Alcon Laboratories, Fort Worth, Tex.), a topical anesthetic.
Approximately 25% of the cornea was abraded using a sterile cotton
applicator, and then amoeba-laden lenses were placed onto the center of
the cornea. The eyelids were then closed by tarsorrhaphy using 6-0 Ethilon sutures (Ethicon, Somerville, N.J.). The contact lenses were
removed 3 to 4 days postinfection, and the corneas were visually
inspected for severity of disease. Visual inspections were recorded
daily during the times indicated. The infections were scored on a scale
of 0 to 5 based on the following parameters: corneal infiltration,
corneal neovascularization, and corneal ulceration. The pathology was
recorded as 0 (no pathology), 1 (<10% of the cornea involved), 2 (10 to 25% involved), 3, (25 to 50% involved) 4, (50 to 75% involved),
and 5 (75 to 100% involved), as described previously
(17). Any animals receiving a score of at least 1.0 for
any parameter were scored as infected. In Chinese hamsters,
Acanthamoeba keratitis resolves at approximately day 21. At
this time, there is a conspicuous absence of corneal opacity, edema,
epithelial defects, and stromal necrosis and inflammation. Histological
examination of eyes termed resolved have never shown any evidence of
trophozoites nor cysts.
MIP-2 and myeloperoxidase (MPO) assays.
Corneas were removed
from infected Chinese hamsters at designated times. All pieces of the
limbus were removed, and the corneas were either immediately used or
flash-frozen in liquid nitrogen and stored at
70°C until tested.
For the detection of MIP-2, corneas were homogenized in 0.5 ml of RPMI
1640 and centrifuged at 10,000 × g for clarification, and protein levels were determined using a Quantikine M mouse MIP-2
enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, Minn.). Corneas were removed on days 1, 2, 3, 5, and 6 postinfection (n = 3 for each time point). The data are expressed as total picograms of MIP-2 per cornea.
MPO activity was determined by the method of Bradley et al.
(
3). Animals were injected with recombinant MIP-2
(rMIP-2),
anti-MIP-2, or control immunoglobulin G (IgG) as described
below.
Briefly, corneas from days 2 and 6 postinfection were
individually
homogenized in 0.5 ml of hexadecyltrimethylammonium
bromide (0.5%
in 50 mM phosphate buffer [pH 6.0]). The homogenate
was then subjected
to three freeze-thaw cycles and centrifuged at
40,000 ×
g for
20 min. After centrifugation, 0.2 ml of
the supernatant was combined
with 1.8 ml of 50 mM phosphate buffer (pH
6.0) containing 0.167
mg of
o-dianisidine hydrochloride per
ml and 0.0005% hydrogen
peroxide. The change in absorbance was
measured spectrophotometrically
at 460 nm. One unit of MPO activity is
defined as the amount degrading
1 µM peroxide per min at 25°C.
Corneas were removed on days 2
and 6 postinfection (
n = 3 for each treatment group on each day).
The data are expressed as
total units of MPO per
cornea.
Anti-MIP-2 and rMIP-2 inoculations.
Goat anti-mouse MIP-2
antibody and mouse rMIP-2 were purchased from R&D Systems. All animals
were treated simultaneously with injections and topical applications.
Anti-MIP-2 was administered via subconjunctival injection 4 h
prior to infection. A solution of 3.33 µg of antibody in 40
µl of
phosphate-buffered saline (PBS) was injected encircling
the entire
subconjunctiva. Identical concentrations of antibody
were then applied
topically (under the lens) using sterile gel-loading
pipette tips at
24, 48, and 72 h postinfection. Goat IgG (Sigma,
St. Louis, Mo.)
controls were administered as above at identical
concentrations. In
several in vivo experiments, the goat IgG was
shown not to react with
Acanthamoeba trophozoites nor to inhibit
their binding to
corneal epithelial cells (data not shown). Infections
were performed in
triplicate (
n = 6 for each
group).
rMIP-2 was administered via intracorneal injection. The corneal surface
was first punctured with a 30-gauge stainless steel
needle, and then
the rMIP-2 was injected using a drawn glass needle
attached to a
syringe dispenser. A 1-µl solution of rMIP-2 in
PBS containing 100 µg/µl was injected just prior to infection.
Identical
concentrations of protein were applied topically (under
the lens) at
24, 48, and 72 h postinfection. Control animals were
injected with
1 µl of PBS. Infections were performed twice (
n = 8 in for
each
group).
Histological examination.
Infected eyes were removed and
stored in 10% Carson's formalin for 24 h. Specimens were then
embedded in paraffin, cut into 4-µm sections using a Reichert
Histostat rotary microtome (Reichert Scientific Instruments, Buffalo,
N.Y.), and placed on polysine hydrobromide-precoated slides
(Polysciences, Warrington, Pa.). Sections were stained with hematoxylin
and eosin, covered with a coverslip, and examined by light microscopy.
Pictures were taken by camera-enhanced light microscopy (BX50; Olympus
Optical, Tokyo, Japan).
Production of anti-Chinese hamster neutrophil antisera.
For
antibody production, two Chinese hamsters were injected with 2.5 ml of
3.0% thioglycolate intraperitoneally. Four hours after injection,
hamsters were sacrificed and the peritoneal cavity was washed with 10 ml of Hanks' balanced salt solution (HBSS). The peritoneal exudate was
layered onto 3 ml of Histopaque and centrifuged at 3,000 rpm for 15 min. The neutrophils were collected, suspended in 1 ml of HBSS, and
immediately used for antibody generation. The initial injection of
106 neutrophils was mixed 1:1 with Freund's complete
adjuvant (Difco Laboratories, Detroit, Mich.) and administered
intramuscularly into a New Zealand White rabbit. Additional injections
were performed without adjuvant once a week for 6 weeks. Blood was
collected from the ear veins of the rabbit starting 4 weeks after the
initial injection. For serum preparation, blood was allowed to clot
overnight at 4°C. Serum was then removed from the clot and
centrifuged at 2,000 × g for 10 min at 4°C. Control
serum was collected from a naive rabbit by ear vein and processed as
stated above. All sera were stored at
20°C.
Serum absorption.
Anti-Chinese hamster antiserum was
absorbed as described by Sekiya et al. (35). Briefly,
neutrophils were harvested by peritoneal lavage as described above and
diluted to 2 × 107 cells/ml in HBSS supplemented with
0.1% bovine serum albumin (BSA). Additionally, spleen, thymus, and
mesenteric lymph nodes were removed, strained through a sterile Falcon
cell strainer (Becton Dickinson and Company, Franklin Lakes, N.J.), and
suspended in HBSS supplemented with 0.1% BSA at 2 × 107 cells/ml. Antiserum was absorbed extensively with
hamster spleen, thymus, and mesenteric lymph node cells to remove
antibodies against Chinese hamster histocompatibility and lymphoid
antigens. The mixtures were then centrifuged at 1,700 × g for 10 min, and the antiserum was removed and tested for
cytotoxicity (see below).
Complement-mediated cytotoxicity assay.
The cytolytic
component of the absorbed antineutrophil serum was tested in a modified
cytotoxicity assay (10). Antiserum was heat inactivated at
56°C for 1 h and diluted 1:50, 1:100, and 1:200 in HBSS
supplemented with 0.1% BSA. Chinese hamster splenocytes, thymocytes,
lymph node cells, and neutrophils were incubated for 1 h at 37°C
in either antiserum or normal serum. Antiserum was removed by
centrifugation, and the cells were then washed in HBSS-BSA. The cells
were incubated in 1 ml of Low-Tox H rabbit complement (Accurate
Chemical Co., Westbury, N.Y.) diluted 1:10 in HBSS-BSA and allowed to
incubate for 30 min at 37°C. All cells were then washed three times
and resuspended in 0.1 ml of HBSS-BSA, and cell viability was
determined by trypan blue exclusion. The cytotoxic index was as
[S (%)
SP (%)/100
SP (%)] × 100, where S (%) is the percentage
of cells that were stained in the presence of antiserum and complement
and SP (%) is the percentage of cells spontaneously stained
with complement alone.
Anti-Chinese hamster antibody inoculations.
The experiments
were performed in two groups. Group 1 was administered 0.5 ml of
absorbed serum injected intraperitoneally daily on days
3,
2,
1,
0, 1, 2, and 3 of infection. Group 2 was administered twice-daily
injections of 0.5 ml of absorbed serum intraperitoneally along with
topical applications of bacitracin (to prevent bacterial infection) for
14 days after infection. Infections were performed as described earlier
(n = 6 for each group of animals in both experiments).
Statistics.
Statistical analyses of MIP-2 and MPO assays
were performed using unpaired Student's t tests; results
are presented as means ± standard errors (SE). Clinical severity
scores were analyzed by the Mann-Whitney test.
 |
RESULTS |
Induction of MIP-2 production in infected Chinese hamster corneas
and its role in recruiting neutrophils.
The presence of MIP-2 has
been established in murine corneas infected with HSVK and
Pseudomonas keratitis and in rat lipopolysaccharide inflammatory studies (33, 40, 50). However, before
beginning in vivo studies in Chinese hamsters, it was important to
determine whether and to what degree MIP-2 is produced in the Chinese
hamster cornea. Infected corneas were removed on days 1, 2, 3, 5, and 6 postinfection and assessed for the presence of MIP-2 by ELISA.
Three days after infection, the corneas displayed a 2.6-fold increase
in MIP-2 production (Fig.
1). This
increase in production
was sustained during the remaining days that
were tested.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
MIP-2 ELISA of Chinese hamster corneas infected with
Acanthamoeba. Corneas were removed from three hamsters at
the indicated times postinfection. Corneal lysates were individually
prepared and assayed for MIP-2. The bars show means ± SE of three
hamster corneas per time point. ***, significantly different from
uninfected control corneas (P < 0.001).
|
|
Corneas from similarly treated animals were examined to determine if
the increased expression of MIP-2 induced the migration
and
accumulation of neutrophils. MPO is an enzyme specific for
neutrophils
and is an accurate reflection of the neutrophil content
in tissues
(
4). The MPO assay was used to determine if rMIP-2
could
stimulate neutrophil recruitment into corneas infected with
Acanthamoeba trophozoites and if neutralization of
endogenously
produced MIP-2 would affect neutrophil infiltration in
response
to corneal
infection.
The results indicated that intracorneal injection of rMIP-2 induced a
fivefold increase in the MPO activity in infected hamsters
compared to
control hamsters treated with control IgG on day 2
postinfection (Fig.
2). However, by day 6, the MPO activity
of
the rMIP-2-treated group returned to baseline levels. These results
demonstrate that MIP-2 is a potent chemoattractant for neutrophils
in
the Chinese hamster model.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 2.
MPO assay of Chinese hamster corneas infected with
Acanthamoeba. Hamster corneas were injected with rMIP-2,
anti-MIP-2, or control IgG and infected with Acanthamoeba
trophozoites. Corneas were removed on days 2 and 6, and corneal lysates
were individually prepared and assayed for MPO activity. Each bar
represents the mean ± SE of three corneas per treatment on both
days. ** and ***, significantly different from IgG-treated
corneas (P < 0.010 and P < 0.001,
respectively).
|
|
To assess whether endogenous levels of MIP-2 were specifically
responsible for recruiting neutrophils, animals were treated
with
anti-MIP-2 via subconjunctival injection and compared to
similarly
treated IgG control animals (Fig.
2). The efficacy of
MIP-2 in inducing
neutrophil infiltration was apparent, as there
was a 30% decrease in
the MPO activity in corneas from hamsters
treated with anti-MIP-2
compared to the IgG group. Thus, a significant
portion of neutrophil
recruitment in
Acanthamoeba keratitis is
attributed to
locally produced MIP-2.
In vivo effects of anti-MIP-2 and rMIP-2 treated animals.
The
functional capabilities of rMIP-2 and anti-MIP-2 at recruiting and
inhibiting neutrophils, respectively, suggest that it would be possible
to manipulate the clinical symptoms of the disease by altering the
levels of neutrophil migration. To test this hypothesis, animals were
treated with either anti-MIP-2 and goat IgG or rMIP-2 and PBS and
infected as described above. The results shown in Fig.
3, typical for all three experiments
involving anti-MIP-2, show that animals treated with anti-MIP-2 had a
more severe and prolonged infection than control IgG-treated animals. At the peak of infection (day 6), the severity of corneal involvement in the anti-MIP-2-treated groups was significantly greater
(P < 0.001) than in the IgG control group.
Moreover, over 80% of the anti-MIP-2 treated animals still
demonstrated evidence of corneal disease at day 18, compared to a 16%
incidence of infection in the IgG animals.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
In vivo effect of anti-MIP-2 treatment on the severity
of Acanthamoeba keratitis in Chinese hamsters. Animals were
subconjunctivally administered either anti-MIP-2 antibody or control
IgG 4 h before infection. Identical concentrations of anti-MIP-2
and control IgG were administered topically on days 1 to 3 postinfection. Infected lenses were removed after 3 days, and corneas
were scored for clinical severity for the period indicated. On day 18 (*), five of six anti-MIP-2-treated animals but only one of six
control animals still demonstrated evidence of disease. Each graph line
represents the mean severity of six animals for the observed times. The
results shown are representative of three separate experiments.
|
|
In contrast, rMIP-2-treated animals displayed a more severe clinical
infection during the initial onset of the disease, yet
the disease
cleared rapidly (Fig.
4). In two
independent experiments,
intracorneal administration of rMIP-2 resulted
in a much milder
clinical course of
Acanthamoeba keratitis
and a rapid acceleration
of the resolution of corneal disease.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 4.
In vivo effect of rMIP-2 treatment on the course of
Acanthamoeba keratitis in Chinese hamsters. Animals were
injected intracorneally with either rMIP-2 or PBS prior to infection.
Identical concentrations of rMIP-2 and PBS were administered on days 1 to 3 postinfection. Infected lenses were removed after 4 days, and
corneas were scored for clinical severity for the observation times
indicated. The two graphs represent two separate experiments
(n = 8 for each treatment group per experiment).
|
|
The histopathological features of the corneas from the various
treatment groups mirrored the clinical observations and the
MPO assays.
Corneas removed from control animals exhibited mild
corneal infections
on day 3, peak infections on day 6, and the
beginning of resolution on
day 9 (Fig.
5A, C, and E). Corneas
in
the anti-MIP-2-treated groups displayed extensive
pathological
symptoms that exceeded those in the normal IgG treatment
group
at all time points examined. Corneas removed from
anti-MIP-2-treated
animals on day 3 displayed little polymorphonuclear
cell (PMN)
involvement, yet stromal thickening was present (Fig.
5B).
By
day 6, anti-MIP-2-treated animals exhibited severe corneal
infections
including increased vascularization and stromal destruction
(Fig.
5D). Histological examination and MPO assays showed little
migration
of neutrophils (Fig.
5J). On day 9, corneal infections were
still
more severe than in control animals (Fig.
5F). In contrast,
corneas
treated with rMIP-2 were heavily infiltrated with neutrophils
and displayed intense stromal thickening immediately on day 3
(Fig.
5B). The neutrophil infiltration was present both in the
stroma and in
the anterior chamber. Six days postinfection, the
number of neutrophils
in the stroma had declined and the anterior
chamber was clear of
neutrophils; by day 9, the corneas had returned
to normal, with little
microscopic evidence of corneal inflammation
(Fig.
5H and I).
Histological examination of eyes injected either
intracorneally with
PBS or subconjunctivally with goat IgG failed
to show a significant
increase in neutrophil migration compared
to untreated contols (data
not shown).

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 5.
Photomicrographs of corneas from Chinese hamsters
untreated, treated with anti-MIP-2 antibody or rMIP-2, and challenged
with amoeba-laden contact lenses. Eyes were removed from untreated (A,
C, and E), anti-MIP-2-treated (B, D, F, and J), and rMIP-2-treated (G
to I) animals on days 3, 6, and 9 postinfection. Untreated corneas
displayed mild corneal swelling and few PMN at day 3 postinfection (A).
On day 6, extensive corneal swelling and neutrophils were present in
the stroma (C). By day 9, the corneal edema and swelling had subsided
(E). Anti-MIP-2-treated corneas on day 3 displayed significant
corneal swelling, edema, and plasma cells, with few macrophages and PMN
in the stroma (B). At day 6, the extensive corneal swelling persisted
while general stromal inflammation increased (B). At higher
magnification, the cornea reveals a high preponderance of mononuclear
cells (J). Note the persistence of stromal swelling and edema on day 9 postinfection (F). rMIP-2-treated animals displayed the greatest
stromal swelling and PMN infiltration at day 3 in both the stroma and
anterior chamber (G). By day 6, PMN infiltration and corneal swelling
were significantly reduced (H). The stromal swelling and edema had
subsided by day 9 postinfection (I). A to I, bars = 70 µm; J,
bar = 25 µm.
|
|
Antibody-mediated complement lysis of Chinese hamster
neutrophils.
A cytolytic antibody to Chinese hamsters was
generated as a tool for depleting neutrophils and confirming the role
of neutrophils in Acanthamoeba keratitis. A rabbit
polyclonal antibody was generated by repeated intramuscular injections
of Chinese hamster neutrophils as described in Materials and Methods.
The antiserum was exhaustively absorbed with Chinese hamster spleen,
thymus, and lymph node cells. In the presence of complement, the
anti-Chinese hamster neutrophil antiserum (1:50) produced 85% lysis of
Chinese hamster neutrophils without demonstrating measurable toxicity
to splenocytes, thymocytes, or lymph node cells (Fig.
6). Similar results were seen at 1:100 and 1:200 dilutions (data not shown).

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 6.
Cytolytic activity of absorbed anti-Chinese hamster
neutrophil antibody on neutrophils, thymocytes, splenocytes, and lymph
node cells. Neutrophils were harvested by peritoneal lavage.
Neutrophils, thymocytes, splenocytes, and lymph node cells (2 × 106) were incubated with 1:50 diluted absorbed antiserum.
Cytotoxicity was assessed by trypan blue exclusion. Each bar shows the
mean ± SE of triplicate counts.
|
|
In vivo effects of anti-Chinese hamster neutrophil antiserum on the
severity of Acanthamoeba keratitis.
Having confirmed
the potency of the rabbit anti-Chinese hamster neutrophil antiserum in
vitro, we next examined the effect of neutrophil depletion on the
clinical course of Acanthamoeba keratitis. Chinese hamsters
were injected intraperitoneally with 1 ml of either antineutrophil
antiserum or normal rabbit serum 3 days before corneal infection.
Antiserum injections resulted in a 60% decrease of differential
leukocytes in peripheral blood without reducing lymphocyte or monocyte
counts after 5 h (data not shown). As shown in Fig.
7, animals treated with single daily injections developed infections that were over twice as severe as those
in control animals. The experiment was terminated after day 10 because
some animals in the anti neutrophil-treated group began to show
symptoms of bacterium-induced keratitis. Corneas displaying bacterial
infections were swabbed and cultured on blood agar plates (Remel,
Lenexa, Kans.) for confirmation of bacterial keratitis and ascertained
to be infected with Staphylococcus. Since neutrophil
regeneration is extremely rapid, a second experiment was performed
using two daily injections of antineutrophil antiserum along with
topical applications of bacitracin to prevent bacterial growth. As
before, treatment with the antiserum exacerbated the severity of the
corneal infections (Fig. 7). In this case, the severity was
approximately three times higher than in the normal rabbit serum
controls. Although corneal infections resolved in all of the control
hamsters, keratitis persisted throughout the entire observation period
in the antineutrophil-treated animals.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 7.
In vivo effect of anti-Chinese hamster neutrophil
antibody treatment on severity of Acanthamoeba keratitis in
Chinese hamsters. Hamsters (n = 6 for each group) were
administered peritoneal injections of either antineutrophil antiserum
or naive rabbit serum 3 days pre- or post-infection either once (top)
or twice (bottom) daily. Infected lenses were removed 4 days
postinfection, and corneas were evaluated for clinical severity for the
observation times indicated. Animals were given single daily injections
of anti-Chinese hamster neutrophil antiserum (top). The experiment was
terminated at day 10 due to the emergence of bacterial keratitis in the
antiserum group. Animals were given twice-daily injections of
anti-Chinese hamster neutrophil antiserum (bottom). Bacitracin was
administered topically for 14 days to prevent bacterial keratitis.
|
|
 |
DISCUSSION |
The purpose of this study was to determine the role of neutrophils
in Acanthamoeba keratitis by selective inhibition of
neutrophil migration in the cornea through anti-MIP-2 antibody
treatment and by elimination of neutrophils by anti-hamster neutrophil
antiserum treatment. Moreover, the contribution of MIP-2 in migration
of neutrophils into the cornea of Chinese hamsters infected with Acanthamoeba was examined. The results showed that high
levels of MIP-2 were initially produced 3 days postinfection and
maintained during the time points evaluated (day 6). The production of
MIP-2 correlated with the migration of neutrophils as shown by
histology, clinical examination, and MPO activity. Yan et al.
(50) reported that MIP-2 is the predominant chemokine that
stimulates the accumulation of the neutrophils in the mouse cornea
after herpes simplex virus type 1 infection. Our results showed that
the kinetics of MIP-2 production are different from those reported with
herpesvirus infection and may be related to differences in the immune
responses to the pathogens. Repeated subconjunctival injections of
anti-MIP-2 antibody had a profound effect on Acanthamoeba
keratitis. Instead of mitigating corneal disease as it does in HSVK,
anti-MIP-2 treatments resulted in more severe keratitis and a prolonged
course of infection. The increased severity of Acanthamoeba
keratitis in anti-MIP-2-treated hamsters was due to a significant
decrease in neutrophil infiltration, as demonstrated by MPO assays on
the corneal buttons from infected hamsters treated with anti-MIP-2 but
not in hamsters treated with an IgG control antibody. The profound
exacerbation of Acanthamoeba keratitis in hamsters treated
with mouse anti-MIP-2 antibody suggests that neutrophils play an
important role in controlling corneal infection with
Acanthamoeba trophozoites.
If neutrophils are important in the resolution of
Acanthamoeba keratitis, then depletion of the host
neutrophil population should exacerbate corneal disease. By contrast,
if neutrophils contribute to the pathogenesis of
Acanthamoeba keratitis, one would expect neutrophil
depletion to mitigate corneal disease. Again, depletion of neutrophils
with anti-Chinese hamster neutrophil antibody resulted in more severe
keratitis, as well as prolonged and more chronic keratitis. The most
likely explanation for the exacerbation of Acanthamoeba
keratitis in Chinese hamsters treated with either anti-MIP-2 antibody
or antineutrophil antibody is that neutrophils act as a first line of
defense and destroy significant numbers of the amoebae. Therefore, the
absence of neutrophils in the cornea may allow invasion of
Acanthamoeba into the cornea, which induces more severe
keratitis. In this regard, in vitro studies demonstrated that
neutrophils are capable of killing Acanthamoeba trophozoites
(37). Unlike HSVK and Pseudomonas keratitis,
where the inhibited migration of neutrophils by anti-mouse MIP-2
antibody ameliorated the clinical symptoms, neutrophils seem to be
important in resolving Acanthamoeba keratitis (33,
50).
The more severe keratitis in anti-MIP-2 and antineutrophil
antibody-treated hamsters suggested that neutrophils clearly have a
protective role in Acanthamoeba keratitis. We suspected that if we induced neutrophil migration into the cornea prior to infection with Acanthamoeba trophozoites, animals would experience
milder keratitis. Injection of recombinant mouse MIP-2 into the cornea resulted in an initial increase in corneal inflammation but ultimately caused a more rapid resolution of keratitis than in PBS-treated hamsters. Moreover, induction of neutrophil infiltration was confirmed histologically and by MPO assay. The initial intense inflammation would
be expected with a large population of neutrophils degranulating into
the local tissue. This increase in MPO, as well as other neutrophil
products, may be responsible for the killing of the trophozoites, thus
limiting the course of the disease in corneas of animals treated with
rMIP-2 compared with those of PBS-treated animals. We suspect that
other phagocytic cells, such as macrophages, influence the incidence
and severity of Acanthamoeba keratitis in MIP-2-treated
animals. In contrast with our findings, other blinding infectious
diseases such as HSVK and Pseudomonas keratitis have a much
milder course of the disease after anti-MIP or antineutrophil treatment
(33, 50). These findings are important because HSVK and
Pseudomonas keratitis are immune-mediated diseases whereas Acanthamoeba keratitis is not. We previously showed that
depletion of conjunctival macrophages using liposomes containing the
macrophagicidal drug dichloromethylene diphosphate exacerbated the
severity and chronicity of Acanthamoeba keratitis in Chinese
hamsters (43). By contrast, activation of the adaptive
immune response in the form of Acanthamoeba-specific
delayed-type hypersensitivity and anti-Acanthamoeba IgG
serum antibodies fails to alter the incidence, severity, or chronicity
of Acanthamoeba keratitis in either the pig or Chinese
hamster model of the disease (27). These results, along
with present findings demonstrating the importance of neutrophils, indicate that the innate immune system plays an important role in
controlling Acanthamoeba keratitis.
 |
ACKNOWLEDGMENTS |
This work was supported by Public Health Service grant EY09756
from the National Institutes of Health, NIAID molecular microbiology training grant AI07520, and an unrestricted grant from Research to
Prevent Blindness, Inc., New York, N.Y.
We thank Robert Lausch, George Stewart, and Kathleen Alford for
assistance with the MPO assay, Elizabeth Mayhew for histology, Darrell
Conger and William Anderson for photographic services, and Steve Fisher
and Al Molai for technical assistance with graphic arts.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Ophthalmology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390. Phone: (214) 648-4732. Fax: (214)
648-9061. E-mail: Hassan.Alizadeh{at}UTSouthwestern.edu.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Alizadeh, H.,
J. Y. Niederkorn, and J. McCulley.
1996.
Acanthamoeba keratitis, p. 1062-1071.
In
J. S. Pepose, G. N. Holland, and K. R. Wilhelmus (ed.), Ocular infection and immunity. Mosby, St. Louis, Mo.
|
| 2.
|
Auran, J. D.,
M. B. Starr, and F. A. Jacobiec.
1987.
Acanthamoeba keratitis.
Cornea
6:2-26[Medline].
|
| 3.
|
Bradley, P.,
R. Christensen, and G. Rothstein.
1982.
Cellular and extracellular myeloperoxidase in pyrogenic inflammation.
Blood
60:618-625[Abstract/Free Full Text].
|
| 4.
|
Bradley, P. P.,
D. A. Priebat,
R. D. Christensen, and G. Rothstein.
1982.
Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker.
J. Investig. Dermatol.
78:206-209[CrossRef][Medline].
|
| 5.
|
Brown, T. J.,
R. T. M. Cursons, and E. A. Keys.
1982.
Amoeba from antarctic soil and water.
Appl. Environ. Microbiol.
44:491-493[Abstract/Free Full Text].
|
| 6.
|
Cerva, L.,
C. Serbus, and V. Skocil.
1973.
Isolation of limax amoeba from the nasal mucosa of man.
Folia Parasitol.
20:97-103.
|
| 7.
|
Centers for Disease Control.
1987.
Acanthamoeba keratitis in soft-contact-lens wearers-United States.
Morbid. Mortal. Wkly. Rep.
36:397-398[Medline], 403-404.
|
| 8.
|
Garner, A.
1988.
Pathology of Acanthamoeba infection, p. 535-539.
In
H. D. Cavanagh (ed.), The cornea: Transactions of the World Congress on the Cornea III. Raven Press, New York, N.Y.
|
| 9.
|
He, Y. G.,
J. P. McCulley,
H. Alizadeh,
M. S. Pidherny,
J. Mellon,
J. E. Ubelaker,
G. L. Stewart,
R. E. Silvany, and J. Y. Niederkorn.
1992.
A pig model of Acanthamoeba keratitis: transmission via contaminated lenses.
Investig. Ophthalmol. Vis. Sci.
33:126-133[Abstract/Free Full Text].
|
| 10.
|
He, Y. G., and J. Y. Niederkorn.
1996.
Depletion of donor-derived Langerhans cells promotes corneal allograft survival.
Cornea
15:82-89[Medline].
|
| 11.
|
He, Y. G.,
J. Y. Niederkorn,
J. P. McCulley,
G. L. Stewart,
D. R. Meyer, and R. E. Silvany.
1990.
In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii.
Investig. Ophthalmol. Vis. Sci.
31:2235-2240[Abstract/Free Full Text].
|
| 12.
|
Kernacki, K. A.,
R. P. Barrett,
J. A. Hobden, and L. D. Hazlett.
2000.
Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in occular bacterial infection.
J. Immunol.
164:1037-1045[Abstract/Free Full Text].
|
| 13.
|
Kernacki, K. A.,
R. P. Barrett,
S. A. McClellan, and L. D. Hazlett.
2000.
Aging and PMN response to P. aeruginosa infection.
Investig. Ophthalmol. Vis. Sci.
41:3019-3025[Abstract/Free Full Text].
|
| 14.
|
Kingston, D., and D. C. Warhurst.
1969.
Isolation of amoebae from the air.
J. Med. Microbiol.
2:27-36[Abstract/Free Full Text].
|
| 15.
|
Kwon, B., and L. D. Hazlett.
1997.
Association of CD4+ T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa keratitis.
J. Immunol.
159:6283-6290[Abstract].
|
| 16.
|
Larkin, D. F. P., and D. L. Easty.
1991.
Experimental Acanthamoeba keratitis. II. Immunological evaluation.
Br. J. Ophthalmol.
75:421-424[Abstract/Free Full Text].
|
| 17.
|
Leher, H.,
K. Kinoshita,
H. Alizadeh,
F. L. Zaragoza,
Y. G. He, and J. Y. Niederkorn.
1998.
Impact of oral immunization with Acanthamoeba antigens on parasite adhesion and corneal infection.
Investig. Ophthalmol. Vis. Sci.
39:2337-2343[Abstract/Free Full Text].
|
| 18.
|
Leher, H. F.,
R. E. Silvany,
H. Alizadeh,
J. Huang, and J. Y. Niederkorn.
1998.
Mannnose induces the release of cytopathic factors from Acanthamoeba castellanii.
Infect. Immun.
66:5-10[Abstract/Free Full Text].
|
| 19.
|
Lyons, T. B., and R. Kapur.
1977.
Limax amoeba in public swimming pools of Albany, Schenectady, and Ransselear Counties, New York: their concentrations, correlations, and significance.
Appl. Environ. Microbiol.
2:27.
|
| 20.
|
Mathers, W. D.,
G. Stevens,
M. Rodrigues,
C. C. Chan,
J. Gold,
G. S. Visvesvara,
M. A. Lemp, and L. Z. Zimmerman.
1987.
Immunopathology and electron microscopy of Acanthamoeba keratitis.
Am. J. Ophthalmol.
103:626-635[Medline].
|
| 21.
|
Mathers, W. D.,
J. E. Sutphin,
R. Folberg,
P. A. Meier,
R. P. Wenzel, and R. G. Elgin.
1996.
Outbreak of keratitis presumed to be caused by Acanthamoeba.
Am. J. Ophthalmol.
121:207-208[Medline].
|
| 22.
|
McCulley, J. P.,
H. Alizadeh, and J. Y. Niederkorn.
1995.
Acanthamoeba keratitis.
CLAO J.
21:73-76[Medline].
|
| 23.
|
Miller, M. D., and M. S. Krangel.
1992.
Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines.
Crit. Rev. Immunol.
12:17-46[Medline].
|
| 24.
|
Mitro, K.,
A. Bhagavathiamai,
O.-M. Zhou,
G. Bobbett,
J. H. McKerrow,
R. Chokshi,
B. Chokshi, and E. F. James.
1994.
Partial characterization of the proteolytic secretions of Acanthamoeba polyphaga.
Exp. Parasitol.
78:377-385[CrossRef][Medline].
|
| 25.
|
Morton, L. D.,
G. L. McLaughlin, and H. E. Whiteley.
1991.
Effects of temperature, amebic strain, and carbohydrates on Acanthamoeba adherence to corneal epithelium in vitro.
Infect. Immun.
59:3819-3822[Abstract/Free Full Text].
|
| 26.
|
Niederkorn, J. Y.
1994.
Immunological barriers in the eye, p. 241-254.
In
R. Goldie (ed.), The handbook of immunopharmacology. Immunopharmacology of epithelial barriers. Academic Press, London, England.
|
| 27.
|
Niederkorn, J. Y.,
H. Alizadeh,
H. F. Leher, and J. P. McCulley.
1999.
The immunobiology of Acanthamoeba keratitis.
Springer Semin. Immunopathol.
21:147-160[Medline].
|
| 28.
|
Niederkorn, J. Y.,
J. E. Ubelaker,
J. P. McCulley,
G. L. Stewart,
D. R. Meyer,
J. A. Mellon,
R. E. Silvany,
Y. G. He,
M. Pidherney,
J. H. Martin, and H. Alizadeh.
1992.
Susceptibility of corneas from various animal species to in vitro binding and invasion by Acanthamoeba castellanii.
Investig. Ophthalmol. Vis. Sci.
33:104-112[Abstract/Free Full Text].
|
| 29.
|
Pazko-Kolva, C.,
H. Yamamoto,
M. Shahamat,
T. K. Sawyer,
G. Morris, and P. R. Colwell.
1991.
Isolation of amoeba and Pseudomonas and Legionella spp. from eyewash stations.
Appl. Environ. Microbiol.
57:163-167[Abstract/Free Full Text].
|
| 30.
|
Pearlman, E.
1997.
Immunopathology of onchocerciasis: a role for eosinophils in onchocercal dermatitis and keratitis.
Chem. Immunol.
66:26-40[Medline].
|
| 31.
|
Pettit, D. A.,
J. Williamson,
G. A. Cabral, and F. Marciano-Cabral.
1996.
In vitro destruction of nerve cell cultures by Acanthamoeba spp.: a transmission and scanning electron microscopy study.
J. Parasitol.
82:769-777[CrossRef][Medline].
|
| 32.
|
Rivera, F.,
F. Medina,
P. Ramirez,
J. Alcocer,
G. Vilaclara, and E. Robles.
1984.
Pathogenic and free-living protozoa cultured from the nasopharyngeal and oral regions of dental patients.
Environ. Res.
33:428-440[Medline].
|
| 33.
|
Rudner, X. L.,
K. A. Kernacki,
R. P. Barrett, and L. D. Hazlett.
2000.
Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation.
J. Immunol.
164:6576-6582[Abstract/Free Full Text].
|
| 34.
|
Schall, T. J., and K. B. Bacon.
1994.
Chemokine, leukocyte trafficking, and inflammation.
Curr. Opin. Immunol.
6:865-873[CrossRef][Medline].
|
| 35.
|
Sekiya, S.,
S. Gotoh,
T. Yamashita,
T. Watanabe,
S. Saitoh, and F. Sendo.
1989.
Selective depletion of rat neutrophils by in vivo administration of a monoclonal antibody.
J. Leukoc. Biol.
46:96-102[Abstract].
|
| 36.
|
Stehr-Green, J. K.,
T. M. Baily, and G. S. Visvesvara.
1989.
The epidemiology of Acanthamoeba keratitis in the United States.
Am. J. Ophthalmol.
107:331-336[Medline].
|
| 37.
|
Stewart, G. L.,
K. Shupe,
I. Kim,
R. E. Silvany,
H. Alizadeh,
J. P. McCulley, and J. Y. Niederkorn.
1994.
Antibody-dependent neutrophil-mediated killing of Acanthamoeba castellanii.
Int. J. Parasitol.
24:739-742[CrossRef][Medline].
|
| 38.
|
Streilein, J. W.,
M. R. Dana, and B. R. Ksander.
1997.
Immunity causing blindness: five different paths to herpes stromal keratitis.
Immunol. Today
18:443-449[CrossRef][Medline].
|
| 39.
|
Thomas, J.,
S. Gangappa,
S. Kanangat, and B. T. Rouse.
1997.
On essential involvement of neutrophils in the immunopathological disease: herpetic stromal keratitis.
J. Immunol.
158:1383-1391[Abstract].
|
| 40.
|
Vaddi, K.,
M. Keller, and R. C. Newton.
1997.
The chemokine factsbook.
Academic Press, Inc., San Diego, Calif.
|
| 41.
|
Van Klink, F.,
H. Alizadeh,
Y. G. He,
J. A. Mellon,
R. E. Silvany,
J. P. McCulley, and J. Y. Niederkorn.
1993.
The role of contact lenses, trauma, and Langerhans cells in the Chinese hamster model of Acanthamoeba keratitis.
Investig. Ophthalmol. Vis. Sci.
34:1937-1944[Abstract/Free Full Text].
|
| 42.
|
Van Klink, F.,
H. F. Leher,
M. J. Jager,
H. Alizadeh,
W. Taylor, and J. Y. Niederkorn.
1997.
Systemic immune response to Acanthamoebia keratitis in the Chinese hamster.
Ocular Immunol. Inflamm.
5:234-244.
|
| 43.
|
Van Klink, F.,
W. M. Taylor,
H. Alizadeh,
M. J. Jager,
N. Van Rooijen, and J. Y. Niederkorn.
1996.
The role of macrophages in Acanthamoeba keratitis.
Investig. Ophthalmol. Vis. Sci.
37:1271-1281[Abstract/Free Full Text].
|
| 44.
|
Visvesvara, G. S.,
S. S. Mirra,
F. H. Brandt,
D. M. Moss,
H. M. Mathews, and A. J. Martinez.
1983.
Isolation of 2 strains of Acanthamoeba castellanii from human tissue and their pathogenicity and isoenzyme profiles.
J. Clin. Microbiol.
6:1405-1412.
|
| 45.
|
Visvesvara, G. S., and J. K. Stehr-Green.
1990.
Epidemiology of free-living amoeba infections.
J. Protozool.
37:25s-33s.
|
| 46.
|
Wang, S. S., and H. A. Feldman.
1967.
Isolation of Hartmannella species from human throats.
N. Engl. J. Med.
277:1174-1179.
|
| 47.
|
Watanabe, K.,
M. Iida,
K. Takaishi,
T. Suzuki,
Y. Hamada,
Y. Iizuka, and S. Tsurufuji.
1993.
Chemoattractants for neutrophils in lipopolysaccharide-induced inflammatory exudate from rats are not interleukin-8 counterparts but gro-gene-product/melanoma-growth-stimulating-activity-related factors.
Eur. J. Biochem.
214:267-270[Medline].
|
| 48.
|
Wolpe, S. D.,
G. Davatelis,
B. Sherry,
B. Beutler,
D. G. Hesse,
H. T. Nguyen,
L. L. Moldawer,
C. F. Nathan,
S. F. Lowry, and A. Cerami.
1988.
Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokine properties.
J. Exp. Med.
167:570-581[Abstract/Free Full Text].
|
| 49.
|
Wolpe, S. D.,
B. Sherry,
D. Juers,
G. Davatelis,
R. W. Yurt, and A. Cerami.
1989.
Identification and characterization of macrophage inflammatory protein 2.
Proc. Natl. Acad. Sci. USA
86:612-616[Abstract/Free Full Text].
|
| 50.
|
Yan, X. T.,
T. M. Tumpey,
S. L. Kunkel,
J. E. Oakes, and R. N. Lausch.
1998.
Role of MIP-2 in neutrophil migration and tissue injury in herpes simplex virus-1-infected cornea.
Investig. Ophthalmol. Vis. Sci.
39:1854-1862[Abstract/Free Full Text].
|
| 51.
|
Yang, Z. T.,
Z. Y. Cao, and N. Panjwani.
1997.
Pathogenesis of Acanthamoeba keratitis-carbohydrate-mediated host-parasite interactions.
Infect. Immun.
65:439-445[Abstract].
|
Infection and Immunity, May 2001, p. 2988-2995, Vol. 69, No. 5
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.5.2988-2995.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Alizadeh, H., Neelam, S., Niederkorn, J. Y.
(2007). Effect of Immunization with the Mannose-Induced Acanthamoeba Protein and Acanthamoeba Plasminogen Activator in Mitigating Acanthamoeba Keratitis. IOVS
48: 5597-5604
[Abstract]
[Full Text]
-
Clarke, D. W., Alizadeh, H., Niederkorn, J. Y.
(2006). Intracorneal Instillation of Latex Beads Induces Macrophage-Dependent Protection against Acanthamoeba Keratitis. IOVS
47: 4917-4925
[Abstract]
[Full Text]
-
Clarke, D. W., Alizadeh, H., Niederkorn, J. Y.
(2005). Failure of Acanthamoeba castellanii to Produce Intraocular Infections. IOVS
46: 2472-2478
[Abstract]
[Full Text]
-
Alizadeh, H., Neelam, S., Hurt, M., Niederkorn, J. Y.
(2005). Role of Contact Lens Wear, Bacterial Flora, and Mannose-Induced Pathogenic Protease in the Pathogenesis of Amoebic Keratitis. Infect. Immun.
73: 1061-1068
[Abstract]
[Full Text]
-
Banerjee, K., Biswas, P. S., Kim, B., Lee, S., Rouse, B. T.
(2004). CXCR2-/- Mice Show Enhanced Susceptibility to Herpetic Stromal Keratitis: A Role for IL-6-Induced Neovascularization. J. Immunol.
172: 1237-1245
[Abstract]
[Full Text]
-
Hurt, M., Neelam, S., Niederkorn, J., Alizadeh, H.
(2003). Pathogenic Acanthamoeba spp. Secrete a Mannose-Induced Cytolytic Protein That Correlates with the Ability To Cause Disease. Infect. Immun.
71: 6243-6255
[Abstract]
[Full Text]
-
Hurt, M., Niederkorn, J., Alizadeh, H.
(2003). Effects of Mannose on Acanthamoeba castellanii Proliferation and Cytolytic Ability to Corneal Epithelial Cells. IOVS
44: 3424-3431
[Abstract]
[Full Text]
-
Marciano-Cabral, F., Cabral, G.
(2003). Acanthamoeba spp. as Agents of Disease in Humans. Clin. Microbiol. Rev.
16: 273-307
[Abstract]
[Full Text]
-
Ruan, X., Chodosh, J., Callegan, M. C., Booth, M. C., Lee, T. D., Kumar, P., Gilmore, M. S., Pereira, H. A.
(2002). Corneal Expression of the Inflammatory Mediator CAP37. IOVS
43: 1414-1421
[Abstract]
[Full Text]